Assignee
GLAXOSMITHKLINE IP NO 2 LTD
GB·68 granted patents·47 pending applications·95 citations·filing 2012–2025
Top patents by PatentIndex Score
115 records- 0195US11459384B2Biopharmaceutical compositionsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2022·Granted Oct 4, 2022·3 cites·25 claims
- 0294US11299541B2Biopharmaceutical compositionsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2021·Granted Apr 12, 2022·3 cites·19 claims
- 0394US11286298B2Biopharmaceutical compositionsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2021·Granted Mar 29, 2022·3 cites·17 claims
- 0494US11274148B2Biopharmaceutical compositionsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2021·Granted Mar 15, 2022·3 cites·18 claims
- 0592US10870695B2Biopharmaceutical compositions comprising interleukin-5 antibodyGLAXOSMITHKLINE IP NO 2 LTD·Filed 2016·Granted Dec 22, 2020·8 cites·12 claims
- 0690US8957104B2Chemical compoundsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2013·Granted Feb 17, 2015·10 cites·12 claims
- 0790US2026049130A1Biopharmaceutical compositionsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2025·Application pending·0 cites
- 0889US11117871B2Crystalline forms of GSK1278863, preparation method and pharmaceutical use thereofGLAXOSMITHKLINE IP NO 2 LTD·Filed 2020·Granted Sep 14, 2021·2 cites·16 claims
- 0988US12187790B2Biopharmaceutical compositionsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2024·Granted Jan 7, 2025·0 cites·17 claims
- 1088US12187791B2Biopharmaceutical compositionsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2024·Granted Jan 7, 2025·0 cites·17 claims
- 1188US12187789B2Biopharmaceutical compositionsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2024·Granted Jan 7, 2025·0 cites·22 claims
- 1288US10034881B22,3-disubstituted 1 -acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2017·Granted Jul 31, 2018·6 cites·4 claims
- 1386US10316054B2Preparation and use of crystalline beta-D-nicotinamide ribosideGLAXOSMITHKLINE IP NO 2 LTD·Filed 2015·Granted Jun 11, 2019·6 cites·20 claims
- 1486US9346840B2Cyclopropylamines as LSD1 inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2014·Granted May 24, 2016·7 cites·12 claims
- 1586US9273069B2Compounds as diacylglycerol acyltransferase inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2015·Granted Mar 1, 2016·4 cites·8 claims
- 1685US10370356B2Pyridinone dicarboxamide for use as bromodomain inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2016·Granted Aug 6, 2019·6 cites·20 claims
- 1785US10196353B2Chemical compoundsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2016·Granted Feb 5, 2019·3 cites·12 claims
- 1885US9040517B2Compounds as diacylglycerol acyltransferase inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2014·Granted May 26, 2015·5 cites·8 claims
- 1983US12454571B2Biopharmaceutical compositionsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2022·Granted Oct 28, 2025·0 cites·13 claims
- 2083US10710963B2Chemical compoundsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2018·Granted Jul 14, 2020·1 cites·4 claims
- 2181US10676503B2Methods for purifying antibodiesGLAXOSMITHKLINE IP NO 2 LTD·Filed 2014·Granted Jun 9, 2020·4 cites·18 claims
- 2280US9902694B2Crystalline formsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2015·Granted Feb 27, 2018·3 cites·8 claims
- 2379US10583112B2Benzo[b]furans as bromodomain inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2017·Granted Mar 10, 2020·2 cites·22 claims
- 2478US2023040299A12,3-disubstituted 1-acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2022·Application pending·0 cites
- 2577US10064854B2Cyclopropylamines as LSD1 inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2017·Granted Sep 4, 2018·1 cites·14 claims
- 2676US10428026B2Pyridinone dicarboxamide for use as bromodomain inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2016·Granted Oct 1, 2019·2 cites·25 claims
- 2775US10858376B2Tricyclic benzoxaborole compounds and uses thereofGLAXOSMITHKLINE IP NO 2 LTD·Filed 2019·Granted Dec 8, 2020·0 cites·18 claims
- 2875US10562852B2Crystalline forms of (R)-1-(1-(methylsulfonyl)propan-2-yl)-4-(trifluoromethyl)-1H-indole-5-carbonitrileGLAXOSMITHKLINE IP NO 2 LTD·Filed 2018·Granted Feb 18, 2020·1 cites·12 claims
- 2975US10202386B2Pyrrolo[3,2-D]pyrimidine derivatives as inducers of human interferonGLAXOSMITHKLINE IP NO 2 LTD·Filed 2015·Granted Feb 12, 2019·2 cites·18 claims
- 3075US10059699B2Tetrahydroquinoline derivatives as bromodomain inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2015·Granted Aug 28, 2018·2 cites·18 claims
- 3175US2025353878A1Methods of Purifying AntibodiesGLAXOSMITHKLINE IP NO 2 LTD·Filed 2025·Application pending·0 cites
- 3275US2023271927A1Crystalline forms of gsk1278863, preparation method and pharmaceutical use thereofGLAXOSMITHKLINE IP NO 2 LTD·Filed 2023·Application pending·0 cites
- 3375US2026035371A1Compounds useful in hiv therapyGLAXOSMITHKLINE IP NO 2 LTD·Filed 2025·Application pending·0 cites
- 3473US11299457B2Chemical compoundsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2020·Granted Apr 12, 2022·0 cites·4 claims
- 3573US10966961B2Pyrazole derivatives as bromodomain inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2018·Granted Apr 6, 2021·1 cites·17 claims
- 3673US10485814B2Nicotinamide riboside analogs and pharmaceutical compositions and uses thereofGLAXOSMITHKLINE IP NO 2 LTD·Filed 2015·Granted Nov 26, 2019·2 cites·18 claims
- 3773US2021053999A1Tricyclic Benzoxaborole Compounds and Uses ThereofGLAXOSMITHKLINE IP NO 2 LTD·Filed 2020·Application pending·0 cites
- 3872US12240853B2Compounds useful in HIV therapyGLAXOSMITHKLINE IP NO 2 LTD·Filed 2020·Granted Mar 4, 2025·0 cites·16 claims
- 3971US11649217B2Crystalline forms of GSK1278863, preparation method and pharmaceutical use thereofGLAXOSMITHKLINE IP NO 2 LTD·Filed 2021·Granted May 16, 2023·0 cites·18 claims
- 4071US2020199219A1Biopharmaceutical compositionsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2020·Application pending·0 cites
- 4170US11478478B22,3-disubstituted 1-acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2020·Granted Oct 25, 2022·0 cites·21 claims
- 4269US10588891B2TRPV4 antagonistsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2017·Granted Mar 17, 2020·1 cites·21 claims
- 4368US10526352B2Tricyclic benzoxaborole compounds and uses thereofGLAXOSMITHKLINE IP NO 2 LTD·Filed 2019·Granted Jan 7, 2020·0 cites·13 claims
- 4466US10927080B2Pyridinone dicarboxamide for use as bromodomain inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2019·Granted Feb 23, 2021·0 cites·8 claims
- 4566US10583139B22,3-disubstituted 1-acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2018·Granted Mar 10, 2020·0 cites·16 claims
- 4666US9242962B2Method of treatmentGLAXOSMITHKLINE IP NO 2 LTD·Filed 2012·Granted Jan 26, 2016·2 cites·4 claims
- 4765US11214582B24-substituted benzoxaborole compounds and uses thereofGLAXOSMITHKLINE IP NO 2 LTD·Filed 2020·Granted Jan 4, 2022·0 cites·20 claims
- 4864US12358945B2Methods for purifying antibodiesGLAXOSMITHKLINE IP NO 2 LTD·Filed 2020·Granted Jul 15, 2025·0 cites·20 claims
- 4963US10308668B2Tricyclic benzoxaborole compounds and uses thereofGLAXOSMITHKLINE IP NO 2 LTD·Filed 2017·Granted Jun 4, 2019·0 cites·22 claims
- 5062US11001556B2Crystalline formsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2020·Granted May 11, 2021·0 cites·12 claims
Showing the top 50 of 115 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →